[{"Assets_0_Q1_USD":340947388.0,"CommonStockSharesOutstanding_0_Q1_shares":92591457.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":168284763.0,"NetIncomeLoss_1_Q1_USD":12037253.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":91091823.0,"StockholdersEquity_0_Q1_USD":172055219.0,"EarningsPerShareBasic_1_Q1_USD":0.13,"Ticker":"ARWR","CIK":"879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","OfficialName":"Arrowhead Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4797362481.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190207"}]